Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,819 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of Continuous Infusion Meropenem PK/PD Target Attainment on C-Reactive Protein Dynamics in Critically Ill Patients With Documented Gram-Negative Hospital-Acquired or Ventilator-Associated Pneumonia.
Troisi C, Cojutti PG, Rinaldi M, Tonetti T, Siniscalchi A, van Hasselt C, Viale P, Pea F. Troisi C, et al. Among authors: rinaldi m. Clin Pharmacokinet. 2024 Nov;63(11):1573-1583. doi: 10.1007/s40262-024-01436-6. Epub 2024 Oct 25. Clin Pharmacokinet. 2024. PMID: 39455501
Comparative Impact of an Optimized PK/PD Target Attainment of Piperacillin-Tazobactam vs. Meropenem on the Trend over Time of SOFA Score and Inflammatory Biomarkers in Critically Ill Patients Receiving Continuous Infusion Monotherapy for Treating Documented Gram-Negative BSIs and/or VAP.
Gatti M, Rinaldi M, Tonetti T, Siniscalchi A, Viale P, Pea F. Gatti M, et al. Among authors: rinaldi m. Antibiotics (Basel). 2024 Mar 25;13(4):296. doi: 10.3390/antibiotics13040296. Antibiotics (Basel). 2024. PMID: 38666972 Free PMC article.
An innovative population pharmacokinetic/pharmacodynamic strategy for attaining aggressive joint PK/PD target of continuous infusion ceftazidime/avibactam against KPC- and OXA-48- producing Enterobacterales and preventing resistance development in critically ill patients.
Cojutti PG, Pai MP, Gatti M, Rinaldi M, Ambretti S, Viale P, Pea F. Cojutti PG, et al. Among authors: rinaldi m. J Antimicrob Chemother. 2024 Nov 4;79(11):2801-2808. doi: 10.1093/jac/dkae290. J Antimicrob Chemother. 2024. PMID: 39159014
Novel CMY-186 variant conferring cross-resistance to cefiderocol and ceftazidime/avibactam in Klebsiella pneumoniae from a critically ill patient during cefiderocol and ceftazidime/avibactam treatment.
Amadesi S, Gatti M, Rinaldi M, Pea F, Viale P, Gaibani P. Amadesi S, et al. Among authors: rinaldi m. Int J Antimicrob Agents. 2024 Apr;63(4):107107. doi: 10.1016/j.ijantimicag.2024.107107. Epub 2024 Feb 6. Int J Antimicrob Agents. 2024. PMID: 38325723 No abstract available.
Impact on clinical outcome of follow-up blood cultures and risk factors for persistent bacteraemia in patients with gram-negative bloodstream infections: a systematic review with meta-analysis.
Gatti M, Bonazzetti C, Tazza B, Pascale R, Miani B, Malosso M, Beci G, Marzolla D, Rinaldi M, Viale P, Giannella M. Gatti M, et al. Among authors: rinaldi m. Clin Microbiol Infect. 2023 Sep;29(9):1150-1158. doi: 10.1016/j.cmi.2023.02.024. Epub 2023 Mar 7. Clin Microbiol Infect. 2023. PMID: 36894053 Free article. Review.
Gut microbiome dynamics and Enterobacterales infection in liver transplant recipients: A prospective observational study.
D'Amico F, Rinaldi M, Pascale R, Fabbrini M, Morelli MC, Siniscalchi A, Laici C, Coladonato S, Ravaioli M, Cescon M, Ambretti S, Viale P, Brigidi P, Turroni S, Giannella M. D'Amico F, et al. Among authors: rinaldi m. JHEP Rep. 2024 Feb 12;6(4):101039. doi: 10.1016/j.jhepr.2024.101039. eCollection 2024 Apr. JHEP Rep. 2024. PMID: 38524669 Free PMC article.
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study.
Giacobbe DR, Labate L, Russo Artimagnella C, Marelli C, Signori A, Di Pilato V, Aldieri C, Bandera A, Briano F, Cacopardo B, Calabresi A, Capra Marzani F, Carretta A, Cattelan A, Ceccarelli L, Cenderello G, Corcione S, Cortegiani A, Cultrera R, De Rosa FG, Del Bono V, Del Puente F, Fanelli C, Fava F, Francisci D, Geremia N, Graziani L, Lombardi A, Losito AR, Maida I, Marino A, Mazzitelli M, Merli M, Monardo R, Mularoni A, Oltolini C, Pallotto C, Pontali E, Raffaelli F, Rinaldi M, Ripa M, Santantonio TA, Serino FS, Spinicci M, Torti C, Trecarichi EM, Tumbarello M, Mikulska M, Giacomini M, Marchese A, Vena A, Bassetti M; CEFI-SITA investigators. Giacobbe DR, et al. Among authors: rinaldi m. Infect Dis Ther. 2024 Sep;13(9):1929-1948. doi: 10.1007/s40121-024-01016-y. Epub 2024 Jul 12. Infect Dis Ther. 2024. PMID: 38995601 Free PMC article.
Colonization and infection due to carbapenemase-producing Enterobacteriaceae in liver and lung transplant recipients and donor-derived transmission: a prospective cohort study conducted in Italy.
Errico G, Gagliotti C, Monaco M, Masiero L, Gaibani P, Ambretti S, Landini MP, D'Arezzo S, Di Caro A, Parisi SG, Palù G, Vespasiano F, Morsillo F, Moro ML, Procaccio F, Ricci A, Grossi PA, Pantosti A, Nanni Costa A; SInT Collaborative Study Group. Errico G, et al. Clin Microbiol Infect. 2019 Feb;25(2):203-209. doi: 10.1016/j.cmi.2018.05.003. Epub 2018 May 22. Clin Microbiol Infect. 2019. PMID: 29800674 Free article.
Infections in liver and lung transplant recipients: a national prospective cohort.
Gagliotti C, Morsillo F, Moro ML, Masiero L, Procaccio F, Vespasiano F, Pantosti A, Monaco M, Errico G, Ricci A, Grossi P, Nanni Costa A; SInT Collaborative Study Group. Gagliotti C, et al. Eur J Clin Microbiol Infect Dis. 2018 Mar;37(3):399-407. doi: 10.1007/s10096-018-3183-0. Epub 2018 Jan 29. Eur J Clin Microbiol Infect Dis. 2018. PMID: 29380226
1,819 results